引用次数
引用: 4,258
H-指数: 30
I10-指数 : 52
出版物: 118
Models of astrocytoma
Demirkan B. Gürsel , Karlyne M. Reilly
Drug Discovery Today: Disease Models 2 ( 1) 77 -83
1
2005
Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes.
Karlyne M. Reilly
CSH Protocols 2016 ( 3)
5
2016
Controlling Genetic Background in Crosses of Mouse Models of Cancer.
Karlyne M. Reilly
CSH Protocols 2016 ( 3)
2016
The role of short-range and long-range signaling in mesoderm induction and patterning duringXenopusdevelopment
Karlyne M. Reilly , Douglas A. Melton
Seminars in Cell & Developmental Biology 7 ( 1) 77 -85
5
1996
Nf1 ; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
Karlyne M. Reilly , Dagan A. Loisel , Roderick T. Bronson , Margaret E. McLaughlin
Nature Genetics 26 ( 1) 109 -113
342
2000
Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth
Krishna P. Devkota , Jennifer Wilson , Curtis J. Henrich , James B. McMahon
Journal of Natural Products 76 ( 1) 59 -63
31
2013
Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.
Jessica J. Hawes , Robert G. Tuskan , Karlyne M. Reilly
Neurogenetics 8 ( 2) 121 -130
36
2007
It Takes a (Dysfunctional) Village to Raise a Tumor
Karlyne M. Reilly , Terry Van Dyke
Cell 135 ( 3) 408 -410
8
2008
Rethinking Brain Tumors: The Fourth Mouse Models of Human Cancers Consortium Nervous System Tumors Workshop
Karlyne M. Reilly , Joshua B. Rubin , Richard J. Gilbertson , Joel R. Garbow
Cancer Research 68 ( 14) 5508 -5511
14
2008
Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD–Dependent Manner
Thomas J. Turbyville , Demirkan B. Gürsel , Robert G. Tuskan , Jessica C. Walrath
Molecular Cancer Therapeutics 9 ( 5) 1234 -1243
35
2010
Chr 19A/J modifies tumor resistance in a sex- and parent-of-origin-specific manner
Jessica C. Walrath , Kristi Fox , Erika Truffer , W. Gregory Alvord
Mammalian Genome 20 ( 4) 214 -223
30
2009
Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5
Jessica Amlin-Van Schaick , Sungjin Kim , Karl W. Broman , Karlyne M. Reilly
Mammalian Genome 23 ( 3) 277 -285
13
2012
The Nf1–/+; Trp53–/+cis Mouse Model of Anaplastic Astrocytoma and Secondary Glioblastoma: Dissecting Genetic Susceptibility to Brain Cancer
Karlyne M. Reilly
Humana Press 93 -118
4
2009
Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis
Jessica J. Hawes , Karlyne M. Reilly
Toxicologic Pathology 38 ( 1) 123 -130
11
2010
The Importance of Genome Architecture in Cancer Susceptibility: Location, Location, Location
Karlyne M. Reilly
Cell Cycle 3 ( 11) 1378 -1382
5
2004
Neurofibromatosis and lessons for the war on cancer
Karlyne M. Reilly
Embo Molecular Medicine 1 ( 4) 198 -200
2009
Comparing analysis engines for generated micro-patterned, actin images
Jason M. Kinser , Stephen Lockett , Thomas Turbyville , Karlyne M. Reilly
international conference on computational advances in bio and medical sciences 1 -5
2013
Quantitative analysis of F-actin redistribution in astrocytoma cells treated with candidate pharmaceuticals.
Stephen Lockett , Chrissie Verma , Alla Brafman , Prabhakar Gudla
Cytometry Part A 85 ( 6) 512 -521
7
2014
The Effects of Genetic Background of Mouse Models of Cancer: Friend or Foe?
Karlyne M. Reilly
CSH Protocols 2016 ( 3)
2
2016
Resistance to Oncolytic Myxoma Virus Therapy in Nf1−/−/Trp53−/− Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon
Franz J. Zemp , Brienne A. McKenzie , Xueqing Lun , Lori Maxwell
PLoS ONE 8 ( 6) e65801
13
2013